343 related articles for article (PubMed ID: 25111081)
1. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.
Gibson TM; Morton LM; Shiels MS; Clarke CA; Engels EA
AIDS; 2014 Sep; 28(15):2313-8. PubMed ID: 25111081
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
4. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
6. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
7. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
Howlader N; Shiels MS; Mariotto AB; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
[TBL] [Abstract][Full Text] [Related]
8. Long-term cancer risk among people diagnosed with AIDS during childhood.
Simard EP; Shiels MS; Bhatia K; Engels EA
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk among participants in the women's interagency HIV study.
Hessol NA; Seaberg EC; Preston-Martin S; Massad LS; Sacks HS; Silver S; Melnick S; Abulafia O; Levine AM;
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):978-85. PubMed ID: 15220706
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.
Shiels MS; Cole SR; Kirk GD; Poole C
J Acquir Immune Defic Syndr; 2009 Dec; 52(5):611-22. PubMed ID: 19770804
[TBL] [Abstract][Full Text] [Related]
11. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology.
Shiels MS; Engels EA
Cancer; 2012 Oct; 118(19):4869-76. PubMed ID: 22359254
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
[TBL] [Abstract][Full Text] [Related]
14. Immune deficiency and risk for malignancy among persons with AIDS.
Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
[TBL] [Abstract][Full Text] [Related]
15. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
[TBL] [Abstract][Full Text] [Related]
17. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034
[TBL] [Abstract][Full Text] [Related]
18. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
19. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.
Kirk O; Pedersen C; Cozzi-Lepri A; Antunes F; Miller V; Gatell JM; Katlama C; Lazzarin A; Skinhøj P; Barton SE;
Blood; 2001 Dec; 98(12):3406-12. PubMed ID: 11719381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
